Exploring public genomics data for population pharmacogenomics. Lakiotaki K, Kanterakis A, Kartsaki E, Katsila T, Patrinos GP, Potamias G. PLoS One. 2017 Aug 3;12(8):e0182138. Posted on April 24, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen. Manson LE, van der Wouden CH, Swen JJ, Guchelaar HJ. Pharmacogenomics. 2017 Jul;18(11):1041-1045. Posted on April 24, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Performance Ratio Based Resource Allocation Decision-Making in Genomic Medicine. Fragoulakis V, Mitropoulou C, Katelidou D, van Schaik RH, Maniadakis N, Patrinos GP. OMICS. 2017 Feb;21(2):67-73. Posted on April 24, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels. Tremmel R, Herrmann K, Engst W, Meinl W, Klein K, Glatt H, Zanger UM. Arch Toxicol. 2017 Oct;91(10):3329-3339. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation. Katsila T, Matsoukas MT, Patrinos GP, Kardamakis D. OMICS. 2017 Aug;21(8):429-439. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics. Sarris K, Komianou A, Patrinos GP, Katsila T. Public Health Genomics. 2017;20(2):142-147. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Exosomes: A Cancer Theranostics Road Map. Panagiotara A, Markou A, Lianidou ES, Patrinos GP, Katsila T. Public Health Genomics. 2017;20(2):116-125. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice. Cecchin E, Roncato R, Guchelaar HJ, Toffoli G; Ubiquitous Pharmacogenomics Consortium. Curr Pharm Biotechnol. 2017;18(3):204-209. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects. Zhou Y, Ingelman-Sundberg M, Lauschke VM. Clin Pharmacol Ther. 2017 Oct;102(4):688-700. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies. Tamm R, Mägi R, Tremmel R, Winter S, Mihailov E, Smid A, Möricke A, Klein K, Schrappe M, Stanulla M, Houlston R, Weinshilboum R, Mlinarič Raščan I, Metspalu A, Milani L, Schwab M, Schaeffeler E. Clin Pharmacol Ther. 2017 May;101(5):684-695. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
